Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
Cell Cycle (Georgetown, Tex.)|December 6, 2003
Cell cycle checkpoint proteins and cellular response to treatment by anticancer agentsGiovanna Damia, Massimo BrogginiEuropean Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Improving the selectivity of cancer treatments by interfering with cell response pathwaysGiovanna Damia, Massimo BrogginiCancers|January 24, 2019
Platinum Resistance in Ovarian Cancer: Role of DNA RepairGiovanna Damia, Massimo BrogginiCancer Treatment Reviews|February 26, 2013
Revisiting ovarian cancer preclinical models: implications for a better management of the diseaseFrancesca Ricci, Massimo Broggini, Giovanna DamiaOncotargets and Therapy|March 7, 2025
The Landscape of PARP Inhibitors in Solid CancersMarta Muzzana, Massimo Broggini, Giovanna DamiaCancer Management and Research|February 5, 2013
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancerMassimo Broggini, Marina Chiara Garassino, Giovanna DamiaCell Cycle (Georgetown, Tex.)|August 25, 2004
Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53Laura Carrassa, Massimo Broggini, Eugenio Erba, et al.Molecular Cancer|June 1, 2017
Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenograftsFrancesca Ricci, Federica Guffanti, Giovanna Damia, et al.Cell Cycle (Georgetown, Tex.)|September 25, 2003
Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sitesLaura Carrassa, Massimo Broggini, Faina Vikhanskaya, et al.Cancer Treatment Reviews|November 29, 2011
Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impactChiara Foroni, Massimo Broggini, Daniele Generali, et al.Pageof 19